Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project.

Adiposity Adult Aged Bile Duct Neoplasms / epidemiology Body Mass Index Carcinoma, Hepatocellular / epidemiology Cholangiocarcinoma / epidemiology Female Humans Liver Neoplasms / epidemiology Male Middle Aged Prospective Studies Waist Circumference Waist-Hip Ratio
abdominal obesity epidemiology gluteofemoral obesity hepatocellular carcinoma intrahepatic cholangiocarcinoma

Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 08 2020
Historique:
received: 22 05 2019
revised: 19 09 2019
accepted: 24 09 2019
pubmed: 5 11 2019
medline: 12 3 2021
entrez: 3 11 2019
Statut: ppublish

Résumé

Obesity is known to be associated with primary liver cancer (PLC), but the separate effects of excess abdominal and gluteofemoral size are unclear. Thus, we examined the association between waist and hip circumference with risk of PLC overall and by histologic type-hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). The Liver Cancer Pooling Project is a consortium of prospective cohort studies that include data from 1,167,244 individuals (PLC n = 2,208, HCC n = 1,154, ICC n = 335). Multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CI) were estimated using proportional hazards regression. Waist circumference, per 5 cm increase, was associated with an 11% increased PLC risk (HR = 1.11, 95%CI: 1.09-1.14), including when adjusted for hip circumference (HR = 1.12, 95%CI: 1.08-1.17) and also when restricted to individuals in a normal body mass index (BMI) range (18.5 to <25 kg/m

Identifiants

DOI: 10.1002/ijc.32760 PMID: 31677159 PMC: PMC7391795
pubmed: 31677159
doi: 10.1002/ijc.32760
pmc: PMC7391795
mid: NIHMS1601453
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

675-685

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016087
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600002C
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA087969
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL043851
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES000260
Pays : United States
Organisme : NIDDK NIH HHS
ID : K24 DK098311
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA058420
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA039742
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600003C
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA186107
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600004C
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA182913
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA164974
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600018C
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA167552
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA CP010158
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA182934
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA047988
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600001C
Pays : United States
Organisme : NCI NIH HHS
ID : K07 CA188126
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL080467
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA167552
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA127003
Pays : United States
Organisme : NHLBI NIH HHS
ID : RC1 HL099355
Pays : United States

Informations de copyright

© 2019 UICC.

Références

Metabolism. 1992 Nov;41(11):1242-8
pubmed: 1435298
Int J Obes Relat Metab Disord. 2004 Mar;28(3):402-9
pubmed: 14724659
Am J Epidemiol. 2001 Dec 15;154(12):1119-25
pubmed: 11744517
Nutr Cancer. 1991;15(3-4):179-86
pubmed: 1866312
Br J Cancer. 2017 May 23;116(11):1486-1497
pubmed: 28441380
J Nutr. 2005 Sep;135(9):2263-70
pubmed: 16140909
Cancer. 2002 May 1;94(9):2490-501
pubmed: 12015775
Am J Clin Nutr. 2004 Mar;79(3):379-84
pubmed: 14985210
Curr Opin Cardiol. 2008 Nov;23(6):591-8
pubmed: 18830075
Cancer Detect Prev. 2007;31(1):12-7
pubmed: 17303348
Diabetologia. 2007 Jun;50(6):1127-39
pubmed: 17393135
Int J Cancer. 2016 Oct 1;139(7):1534-45
pubmed: 27244487
PLoS One. 2017 May 11;12(5):e0177175
pubmed: 28493988
Clin Liver Dis. 2015 May;19(2):223-38
pubmed: 25921660
Am J Nurs. 1978 Jun;78(6):1039-40
pubmed: 248266
Metabolism. 2014 May;63(5):607-17
pubmed: 24629562
Am J Epidemiol. 1992 Jul 15;136(2):192-200
pubmed: 1415141
Obes Rev. 2007 Jul;8(4):307-26
pubmed: 17578381
Nat Rev Cancer. 2015 Aug;15(8):484-98
pubmed: 26205341
Am J Epidemiol. 2009 Apr 1;169(7):837-47
pubmed: 19224980
Breast Cancer Res Treat. 1991 May;18 Suppl 1:S23-6
pubmed: 1873553
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Obes Rev. 2010 Jan;11(1):11-8
pubmed: 19656312
J Steroid Biochem Mol Biol. 2010 Oct;122(1-3):65-73
pubmed: 20035866
Obes Res. 2004 Mar;12(3):482-7
pubmed: 15044665
Am J Clin Nutr. 1992 May;55(5):950-4
pubmed: 1570802
J Am Med Womens Assoc (1972). 1995 Mar-Apr;50(2):56-8
pubmed: 7722208
J Clin Endocrinol Metab. 2017 Dec 1;102(12):4588-4595
pubmed: 29029113
J Obes. 2013;2013:454285
pubmed: 23762536
N Engl J Med. 1989 Jul 20;321(3):129-35
pubmed: 2664509
J Womens Health Gend Based Med. 2000 Jan-Feb;9(1):19-27
pubmed: 10718501
Endocr Rev. 2000 Dec;21(6):697-738
pubmed: 11133069
Obes Res. 2001 Oct;9(10):644-6
pubmed: 11595782
BMC Med Res Methodol. 2016 May 04;16:49
pubmed: 27145829
Lancet. 2005 Nov 5;366(9497):1640-9
pubmed: 16271645
Br J Cancer. 2015 Mar 31;112(7):1266-72
pubmed: 25742475
Ann Epidemiol. 2003 Oct;13(9 Suppl):S5-17
pubmed: 14575938
Public Health Nutr. 2004 Sep;7(6):723-7
pubmed: 15369609
Am J Epidemiol. 1988 Oct;128(4):740-8
pubmed: 3421240
Am J Gastroenterol. 2018 Oct;113(10):1494-1505
pubmed: 30177781
Biometrics. 1978 Dec;34(4):541-54
pubmed: 373811
Diabetologia. 2002 Sep;45(9):1201-10
pubmed: 12242452
Eur J Cancer. 2009 Mar;45(5):747-55
pubmed: 19117750
Int J Obes Relat Metab Disord. 2001 May;25(5):652-61
pubmed: 11360147
Circulation. 2008 Apr 1;117(13):1658-67
pubmed: 18362231
Cancer Res. 2016 Oct 15;76(20):6076-6083
pubmed: 27742674
N Engl J Med. 1990 Oct 11;323(15):1026-32
pubmed: 2215561
Int J Obes Relat Metab Disord. 2004 Jun;28(6):741-7
pubmed: 15052280
Int J Obes (Lond). 2010 Jun;34(6):949-59
pubmed: 20065965
J Hepatol. 2012 Mar;56(3):704-13
pubmed: 22120206
Am J Clin Nutr. 2002 May;75(5):936-43
pubmed: 11976170
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Andrea A Florio (AA)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Peter T Campbell (PT)

Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA.

Xuehong Zhang (X)

Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA.

Anne Zeleniuch-Jacquotte (A)

Department of Population Health, New York University School of Medicine, New York, NY.

Jean Wactawski-Wende (J)

Department of Epidemiology and Environmental Health, University at Buffalo, Buffalo, NY.

Stephanie A Smith-Warner (SA)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.

Rashmi Sinha (R)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Tracey G Simon (TG)

Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

Howard D Sesso (HD)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.

Catherine Schairer (C)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
ORCID: 0000-0001-7671-4972

Lynn Rosenberg (L)

Slone Epidemiology Center, Boston University, Boston, MA.

Thomas E Rohan (TE)

Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY.

Kim Robien (K)

Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington, DC.

Andrew G Renehan (AG)

Faculty Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom.

Mark P Purdue (MP)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
ORCID: 0000-0003-1177-3108

Jenny N Poynter (JN)

Division of Pediatric Epidemiology and Clinical Research and Masonic Cancer Center, University of Minnesota, Minneapolis, MN.
ORCID: 0000-0002-8460-3938

Julie R Palmer (JR)

Slone Epidemiology Center, Boston University, Boston, MA.

Christina C Newton (CC)

Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA.

Yunxia Lu (Y)

Department of Population Health and Disease Prevention, Program in Public Health, University of California Irvine, Irvine, CA.

Martha S Linet (MS)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Linda M Liao (LM)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

I-Min Lee (IM)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.

Jill Koshiol (J)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Cari M Kitahara (CM)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
ORCID: 0000-0001-6416-4432

Victoria A Kirsh (VA)

Epidemiology Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Jonathan N Hofmann (JN)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Barry I Graubard (BI)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Edward Giovannucci (E)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.

John M Gaziano (JM)

Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
VA Boston Healthcare System, Boston, MA.

Susan M Gapstur (SM)

Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA.

Neal D Freedman (ND)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Jane Demuth (J)

Information Management Services Inc, Silver Spring, MD.

Dawn Q Chong (DQ)

Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.

Andrew T Chan (AT)

Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA.
Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA.

Julie E Buring (JE)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.

Patrick T Bradshaw (PT)

Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, CA.

Laura E Beane Freeman (LE)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Katherine A McGlynn (KA)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
ORCID: 0000-0003-2329-9933

Jessica L Petrick (JL)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Slone Epidemiology Center, Boston University, Boston, MA.
ORCID: 0000-0001-6580-450X

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes physiologiques › Constitution physique › Composition corporelle › Répartition du tissu adipeux › Adiposité › Abdominal and gluteofemoral size and risk of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Abdominal and gluteofemoral size and risk of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Abdominal and gluteofemoral size and risk of...
questionsmedicales.fr › Maladies de l'appareil digestif › Tumeurs de l'appareil digestif › Tumeurs des voies biliaires › Tumeurs des canaux biliaires › Abdominal and gluteofemoral size and risk of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Biométrie › Anthropométrie › Indice de masse corporelle › Abdominal and gluteofemoral size and risk of...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du foie › Tumeurs du foie › Carcinome hépatocellulaire › Abdominal and gluteofemoral size and risk of...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs épithéliales épidermoïdes et glandulaires › Carcinomes › Adénocarcinome › Cholangiocarcinome › Abdominal and gluteofemoral size and risk of...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Abdominal and gluteofemoral size and risk of...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du foie › Tumeurs du foie › Abdominal and gluteofemoral size and risk of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Abdominal and gluteofemoral size and risk of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Abdominal and gluteofemoral size and risk of...
questionsmedicales.fr › Phénomènes physiologiques › Constitution physique › Poids et mesures du corps › Tour de taille › Abdominal and gluteofemoral size and risk of...
questionsmedicales.fr › Phénomènes physiologiques › Constitution physique › Poids et mesures du corps › Rapport taille-hanches › Abdominal and gluteofemoral size and risk of...